Funding Neuro

Parkinson's Disease Ambroxol Phase 3 Clinical Trial

Funding Neuro is joining with Cure Parkinson's, Parkinsons UK, the Van Andel Institute & the John Black Foundation to fund this trial at a total cost of £5.4m. It is hoped that there will be 330 participants in this trial which will run over 2 years
RCN SC042061

Be a fundraiser

Create your own fundraising page and help support this cause.

Start fundraising


This trial, run by Professor Tony Schapira of the UCL Clinical Trials Unit across up to a dozen centres in the UK, aims to confirm if Ambroxol can successfully slow the progression of Parkinson's disease. Parkinson's is generally associated with the build up of proteins inside cells and by boosting the cellular waste disposal system it is thought that this could slow the progression of Parkinson's by improving the function of neurons.

Ambroxol has been demonstrated to be effective at improving the clearance of waste products from cells. There is extensive safety data available for this drug, particularly at the dosage expected to be used in this trial.

About the charity

Funding Neuro

Verified by JustGiving

RCN SC042061
We fund research that will lead to treatments and cures for neurological conditions, we bring researchers together and patients of all disorders, to share ideas, support innovation and deliver results. We are currently involved in trials for DIPG brain tumours, Parkinson's Disease and MND.

Donation summary

Total raised
+ £7.50 Gift Aid
Online donations
Offline donations
Direct donations
Donations via fundraisers

* Charities pay a small fee for our service. Find out how much it is and what we do for it.